To achieve precision, scientists and engineers must bake pharmaceutical calibrations and instrumentation maintenance into their workflows. Doing so supports a reliable manufacturing process, from raw material and diagnostic reagent testing to quality assurance.

The result – high-quality pharmaceuticals produced at the speed required to meet public demand.

This article explores instrument calibrations in the pharmaceutical industry.

Key Takeaways

• Pharmaceutical calibration and instrumentation maintenance are essential for regulatory compliance, drug consistency, and patient safety

• Modern drug manufacturing and testing regulations provide a framework for pharmaceutical calibrations and instrumentation

• Different types of pharmaceutical testing equipment require regular calibration to ensure accuracy before batch release

• Calibration methods for laboratory instruments depend on the equipment, environment, and regulatory requirements

• Instrument calibration within Process Analytical Technology (PAT) systems supports real-time process control

• Manufacturers can apply calibration methods across many testing processes

Understanding Pharmaceutical Calibrations and Instrumentation

Pharmaceutical calibration is the process of checking and adjusting instruments against standards set by key regulatory agencies.

Pharmaceutical companies must perform regular checks and calibrations on instrumentation, including:

• pH meters
• Pressure gauges
• Flow meters
• Balances and scales
• Temperature sensors
• Spectrophotometers
• Chromatography systems

These instruments are incredibly precise. However, they’re still prone to wear and environmental factors that impact performance.

Instrument drift is a common challenge for scientists and pharmaceutical engineers. It refers to the gradual degradation of an instrument’s measurement accuracy.

Drift affects sensors, scales, meters, and production equipment. It’s caused by temperature variations, mechanical stress, and age. Unmonitored drift can result in inaccuracies that compromise a drug’s efficacy and safety.

Regular pharmaceutical calibrations and instrumentation adjustments detect drift and other inaccuracies, allowing teams to make calculated changes.

Historical Development of Calibration in the Pharmaceutical Industry

Pharmaceutical manufacturing and testing processes were predominantly manual in the first half of the twentieth century. Drug consistency and reproducibility were far more difficult to achieve in this environment.

Events like the thalidomide scandal, which involved over 10,000 children being born with birth defects, prompted many countries to introduce more stringent pharmaceutical testing and licensing guidelines.

The Food and Drug Administration (FDA) published the Good Manufacturing Practices (GMP) regulations for pharmaceutical manufacturing in 1963. This set quality standards for the production, control, and storage of drugs.

Updates to the GMP established standards and methods for pharmaceutical calibrations and instrumentation. They also required traceable calibration records and protocols that support precision instrumentation.

The FDA introduced Process Analytical Technology (PAT) in 2004. This encouraged the use of inline and online sensors that support the real-time monitoring of critical production parameters.

Today, AI and machine learning help pharmaceutical manufacturers analyse calibration data, predict instrument drift, and manage calibration schedules.

Meeting Regulatory Compliance

Regulatory compliance is integral to pharmaceutical manufacturing. Agencies like the FDA, European Medicines Agency, and the Medicines and Healthcare products Regulatory Agency require companies to maintain programmes for pharmaceutical calibration and instrumentation adjustments.

Calibration requirements appear in the following regulatory frameworks:

• Current Good Manufacturing Process (cGMP) – Ensures the identity, strength, quality, and purity of drugs by requiring pharmaceutical companies to adequately control manufacturing operations
• The International Council for Harmonisation “Q10 Pharmaceutical Quality Systems” (ICH Q10) – Provides a framework by which pharmaceutical manufacturers can manage quality throughout the entire production lifecycle.
• FDA 21 CFR Part 211 – Mandates that all automatic, mechanical, or electronic equipment used in pharmaceutical manufacturing be regularly calibrated

Pharmaceutical calibrations and instrumentation programmes must demonstrate traceability. Every calibration should link to a national or international measurement standard. This ensures results are comparable across facilities and over time.

Companies must also create and maintain up-to-date calibration records. These documents are crucial for successful site inspections. They demonstrate to auditors that instruments were calibrated on time, that inconsistencies were investigated, and that corrective measures were taken.

Non-compliance with calibration frameworks may result in drug recalls or the loss of manufacturing authorisation.

Types of Analytical Instruments That Require Calibration

Pharmaceutical testing equipment includes everything from basic laboratory tools to highly specialised analytical devices. Each instrument has its own calibration requirements and tolerances.

Analytical instruments that require regular calibration include:

• Balances and weighing systems – Critical for measuring active pharmaceutical ingredients, biological buffers, and excipients with precision instrumentation
• Temperature monitoring instruments – Used in stability chambers, autoclaves, and storage areas
• pH meters and conductivity analysers – Used in process control and quality testing
• Spectrophotometers and chromatography systems – Used extensively in analytical instrument calibration for identity and purity testing
• Pressure gauges and flow meters – Essential for performance monitoring and verification in equipment like vial filling systems

Calibration complexity for these instruments varies.

For example, calibrating a basic thermometer may take minutes. However, calibrating a chromatography system requires a structured approach to examine hardware, software, and performance criteria.

Calibration Methods for Laboratory Equipment

There are several approaches to laboratory equipment calibration. The right method depends on the instrument, its importance, and the regulatory environment.

The most common approaches in pharmaceutical settings are comparison calibration, internal calibration, and multi-point calibration.

Comparison calibration involves measuring a reference standard and comparing the instrument’s output against it. This method is useful for balances and thermometers, where an accuracy reference is readily available.

Also referred to as self-calibration, internal calibration involves automated functionality within the instrument itself. Moisture analysers, viscometers, and electronic scales often have this feature. Internal calibration facilitates automatic checks, but external calibration is typically required for regulatory compliance.

Multi-point calibration generates a calibration curve across a range of values. Spectrophotometers and pH meters require multi-point calibration to confirm their performance across the full range.

Process Analytical Technology (PAT) Approaches

Process analytical technology has revolutionised production and quality control in the pharmaceutical industry. Rather than testing a full batch after production, PAT enables real-time monitoring and control of manufacturing processes as they happen.

Instruments within PAT systems include near-infrared (NIR) spectrometers, Raman probes, and in-line particle size analysers. These instruments generate continuous data streams during production, allowing operators to detect and correct deviations before they result in a failed batch.

Calibration is integral to the reliability of PAT systems. For example, a NIR spectrometer used for monitoring continuous chemical blending must be calibrated with models that account for variability in raw materials and environmental conditions.

Pharmaceutical calibrations and instrumentation requirements for PAT tools are more complex than those for traditional laboratory instruments. This is a result of their continuous operation and influence on manufacturing decisions.

Regulatory agencies have actively encouraged the use of PAT systems. They help drug manufacturers reduce testing costs, shorten release times, and gain a better understanding of their processes. These benefits support stronger regulatory compliance.

Calibration Applications in Pharmaceutical Testing

Pharmaceutical companies use instrument calibration for various testing processes, from analysing incoming raw materials to final quality assurance. Each application includes its own set of instruments, calibration timelines, and criteria.

In raw material testing, precision instrumentation confirms that incoming ingredients meet specifications before the manufacturing process. Balances, spectrometers, and moisture analysers all require verified calibration.

During manufacturing, calibrated instruments monitor critical process parameters such as temperature, pressure, and mixing times. These readings feed into batch records and digital quality management systems that automatically flag anomalies.

In quality control laboratories, pharmaceutical testing equipment must undergo regular calibration. Chromatography systems, dissolution apparatuses, and Karl Fischer titrators require documented, traceable calibration records before batch release.

Stability testing is the evaluation of a drug’s quality over time under different environmental factors. Instruments and storage chambers used in stability testing must maintain consistent conditions over months or years.

Calibration schedules for stability testing tend to be more frequent. Inconsistencies require a documented assessment of the integrity of a stored sample.

Conclusion

Pharmaceutical calibrations and instrumentation adjustments underpin the accuracy, consistency, and regulatory compliance in drug development and manufacturing. From analytical instrument calibration in labs to real-time monitoring in PAT systems, a well-managed calibration programme protects product quality and improves patient safety. For any pharmaceutical company, investing in reliable calibration practices is a crucial safeguard.

Advances in home construction have transformed the industry in recent years. There’s now an emphasis on energy efficiency, durability, indoor air quality, and sustainability.

Below, we examine five essential materials involved in the construction industry and break down their basic chemistry.

Key Takeaways

• Construction materials contain a wide range of chemicals that improve a home’s structural integrity and durability

• Cavity wall insulation contains chemicals that help reduce heat loss and prevent leaking

• Chemicals in glass help it withstand the high temperatures required to shape it into windows and skylights

• The chemicals in cement help it set after the mixing process

• Sand contains naturally occurring chemicals and is used to make many construction materials

• Steel is used to provide structural support throughout the home construction process

Cavity Wall Insulation

Many homes have cavity walls. These are walls with two layers of material and a gap between them. Cavity wall insulation goes inside this gap to prevent rainwater from penetrating the wall and reduce heat loss.

Cavity wall insulation used to contain Urea Formaldehyde (UF) foam. This is a water-based material that was directly injected into brickwork. It’s made of a mixture of urea formaldehyde resin (an acidic foaming agent) and a propellant such as air.

Today, builders use different materials that are safer and offer more reliable insulation. One of the most common is mineral wool insulation, which contains the following construction chemicals:

• Silicon dioxide
• Calcium oxide
• Magnesium oxide
• Aluminum oxide

Mineral wool insulation works by forming a thermal barrier inside the cavity wall gap. It contains thousands of tiny fibres that form pockets of air. This prevents air movement inside the gap, reducing the amount of heat that can escape.

Glass

Glass is an essential material in home construction. It’s used in windows, doors, and skylights.

The construction chemicals found in glass include:

• Soda
• Silicon dioxide
• Sodium oxide
• Calcium oxide (lime)
• Magnesium oxide
• Aluminium oxide
• Iron oxide
• Boron oxide
• Alumina

The state of glass is quite unique. The solid state is produced by cooling molten material, so the arrangement of atoms is similar to that of a liquid.

Lead oxide produces a gas that’s easier to melt and shape. Boron oxide and alumina help to create gas that can withstand temperature changes. Previously, increases and decreases in temperature would weaken glass and cause it to break, possibly causing injuries.

The glass that’s usually used in windows is known as soda lime glass. It’s used because of its low cost and ability to be shaped and melted. It is, however, less chemically resistant than some other types of glass. Soda lime glass is mainly composed of silica (sand), soda, and lime.

Cement

Homes and commercial buildings require large amounts of cement. It’s used in foundations, walls, drives, and walkways.

Making cement requires the use of several construction chemicals. The following are combined as raw materials before the mixing process:

• Calcium oxide
• Silicon dioxide
• Alumina
• Iron oxide
• Magnesium oxide

The chemical composition has to be controlled in order for cement to be effective. For example, silicon dioxide and calcium oxide are great for increased strength, but too much of them can increase the time it takes for cement to set.

Aluminium oxide, on the other hand, has a property that actually helps the material to set.

Iron oxide colours the cement, as well as helping the fusion of materials. Magnesium oxide is a naturally occurring mineral which should be kept to a minimum. If the content exceeds 5%, it will cause cracks and weaken the structure.

Sand

Many people don’t realise the significant role sand plays in home construction. It’s a raw material used to make concrete, mortar, glass, plaster, and asphalt.

Sand is a naturally occurring substance that contains several construction chemicals, including:

• Silicon dioxide
• Calcium carbonate
• Chlorite

A common constituent of sand is silicon dioxide (or silica). It’s ideal in the construction industry, as it has strong covalent bonds and a high melting and boiling point.

Sand will undergo various treatments and processes to produce the desired grade for a particular application. Depending on its properties, it may be used in various building materials.

Calcium carbonate (in limestone form) isn’t used by itself in the construction industry due to its vulnerability to acid rain. Instead, it’s used as a raw substance for building materials. Interestingly, calcium carbonate is also used in paper and baby nappies.

Steel

Builders use steel throughout the home construction process. It provides structural support, reinforces concrete, and is found in window frames and doors.

Steel contains many common construction chemicals, including:

• Manganese
• Phosphorus
• Sulphur
• Nickel
• Chromium
• Vanadium

Due to its strength, steel is often used as beams to support buildings. It’s durable and boasts a high strength-to-weight ratio compared to many other building materials. Additionally, steel is fire-resistant and is not an organic material, so it won’t rot or crack.

Vanadium is a chemical element which occurs naturally in mineral and fossil fuel deposits. It is added to steel to make it stronger. The industrial vanadium compound, vanadium pentoxide, is used as a catalyst for the production of sulphuric acid.

Conclusion

The structural integrity and efficiency of modern homes rely on a blend of chemical compounds that provide strength, insulation, and durability. By understanding the chemistry behind essential building materials, the construction industry continues to work toward safer and more sustainable building practices.

With nearly 50 years of experience, we have the expertise needed to deliver high-quality chemical solutions to partners around the world.

Watch Our Video to Learn About Our Chemical Manufacturing Services

Flexible Chemical Manufacturing

ReAgent offers chemical manufacturing services right from initial concept through to final delivery.

Whether our customers have an existing formulation or need help developing one from scratch, our in-house chemists provide expert guidance every step of the way.

We can manufacture a variety of batch sizes, from small bespoke blends to large-volume production runs. This level of flexibility helps our customers to scale efficiently.

Our Production Capabilities

Operating from our 60,000 sq.ft. factory, we’re equipped to handle significant production demands. We can manufacture over 100,000 litres of chemicals per day, making us a trusted partner for high-volume supply.

Our factory includes a range of mixing vessels, an automated filling line, and an industrial-scale water production plant. We can fill various container types, from small bottles and drums to IBCs and road tankers.

For products requiring stricter environmental control, we use Class 7 and 8 cleanrooms that support precision and consistency. In addition, our dedicated flammable handling areas enable us to safely process specialist or hazardous materials.

Sustainability is central to our operation. A rooftop solar farm powers our factory, reducing our carbon footprint while supporting efficient, large-scale production.

Stringent Quality Assurance

Quality is central to everything we do. Every batch undergoes rigorous testing in our on-site laboratory. This ensures consistency, safety, and compliance with customer specifications.

Our commitment to excellence is reflected in our internationally recognised certifications:

• ISO 9001 for quality management
• ISO 14001 for environmental management
• ISO 13485 for medical device quality standards
• ISO 45001 for occupational health and safety

ReAgent has also received multiple industry awards, including the prestigious King’s Award for Enterprise. This reflects our culture of continuous improvement and operational excellence.

Dependable Customer Support

Our technical capabilities are backed by outstanding customer service. We work closely with customers to understand their needs, offering responsive communication, reliable supply chain management, and bespoke chemical manufacturing solutions.

By combining technical expertise with a collaborative approach, we ensure our customers receive high-quality products and dependable support.

For businesses seeking a chemical manufacturing partner that delivers at scale without compromising on quality, ReAgent offers a proven solution – advanced facilities, robust quality control, and a commitment to customer success.

X-ray fluorescence (XRF) is one of many tools pharmaceutical companies use to enhance accuracy and quality control during drug production. This technology detects, quantifies, and analyses inorganic impurities.
There are several applications of XRF in pharmaceuticals manufacturing. It screens raw materials for toxins such as lead or mercury and checks final products for quality. XRF also reduces the need for costly laboratory analysis.

As demand for specialised drugs rises, XRF is an invaluable tool for efficient production and compliance.

Key Takeaways

• X-ray fluorescence spectroscopy supports the non-destructive testing of raw materials used in pharmaceutical manufacturing

• XRF delivers precise elemental analysis to detect levels of toxic trace metals and impurities found in Active Pharmaceutical Ingredients (APIs) and inactive materials

• XRF plays a vital role in the drug formulation process, ensuring quality, consistency, safety, and drug efficacy

• Regulatory compliance is one of the most important applications of XRF in pharmaceuticals manufacturing

X-Ray Fluorescence Spectroscopy

Pharmaceutical manufacturing involves various spectroscopic techniques for product analysis. XRF spectroscopy is becoming increasingly popular as an alternative to traditional laboratory screening.

The process involves shooting a drug sample with high-energy X-rays. This destabilises atoms by knocking inner-level electrons out.

Higher-level electrons quickly restabilise the atom by filling the empty spots. In doing so, they release a burst of energy in the form of an X-ray. This burst of energy is unique to the electron’s elemental makeup. Think of it like a fluorescent fingerprint.

X-ray fluorescence spectroscopy offers several benefits:

• It’s non-destructive, allowing manufacturers to reuse APIs.
• It provides results in as little as 30 minutes, speeding the manufacturing and quality control process.
• It doesn’t require the use of harmful acids or gases.
• It can analyse packing materials for toxic substances.
• It supports regulatory compliance by detecting toxic elements, improving the chance of a drug’s approval.

Companies can harness these benefits by integrating different applications of XRF in pharmaceuticals manufacturing.

XRF for Elemental Analysis

Drug quality, consistency, and safety depend on stringent elemental analysis and testing. XRF makes this process fast and easy.

For pharmaceutical manufacturers, knowing the elemental composition of raw materials, APIs, and excipients (inactive substances) is imperative. It ensures drug purity and reduces the chance of harmful trace metals or residual chemical reagents ending up in final products.

Detecting and analysing trace quantities of impurities or elements if an API is challenging. These materials can present at levels as small as parts-per-billion (ppb) or have chemical structures similar to the API.

Using XRF imaging for elemental analysis provides a reliable solution to these challenges, allowing companies to produce quality drugs at high volumes.

Toxic Metal Detection

Noble metals like palladium and platinum are often required during API synthesis. X-ray fluorescence can detect them at parts-per-million, so they can be removed before batch production.

XRF also screens for toxic heavy metals like lead or arsenic that make their way into drug formulations from raw materials or leaching from manufacturing equipment. Early detection allows for the removal of heavy metals before production.

Raw Material Analysis

Drugs contain a wide range of raw materials, from APIs and binders to biological buffers that regulate pH levels. All of these raw materials must be tested for purity.

XRF facilitates rapid testing of incoming raw materials, detecting impurities, and ensuring the consistency of all necessary components. It also spots elemental discrepancies common in counterfeit drugs.

Liquid Analysis

Impurities in water or solvents can compromise the quality of a drug. X-ray fluorescence spectroscopy detects these impurities at extremely low levels.

Traditional instruments like Inductively Coupled Plasma Spectrometry require acids to digest drug samples before testing. XRF can test liquids right away, speeding the quality assurance process.

The Role of XRF in Drug Formulation

The drug formulation process involves combining an API with inactive ingredients to produce tablets, injections, or capsules. The goal is to create medicines that are safe, stable, and effective.

The following applications of XRF in pharmaceuticals manufacturing support end-to-end drug formulation, from ingredient selection to product release:

• Raw material qualifications – All raw materials must be tested and verified prior to drug formulation. XRF imaging supports the timely confirmation of raw material elements and tests for impurities.
• Excipient compatibility – Trace metals in excipients can cause API degradation. Manufacturers use XRF to ensure excipients are suitable for use with the required API.
• Process monitoring and control – XRF supports real-time process monitoring and control by screening samples for elemental residues in water during chemical mixing. It also integrates with Process Analytical Technology systems to provide real-time elemental monitoring.
• Drug uniformity and stability – XRF imaging supports elemental mapping, which shows API distribution across a tablet. It also monitors elemental stability over time, supporting efficacy and safety throughout a drug’s shelf life.
• Liquid and semi-solid development – Elemental analysis is critical in the formulation of creams, gels, solutions, and suspensions. X-ray fluorescence spectroscopy detects levels of metal impurities that could compromise the safety and shelf life of these drugs.

Pharmaceutical manufacturers use XRF in conjunction with other techniques like Inductively Coupled Plasma Spectroscopy. X-ray fluorescence spectroscopy devices are small, portable, and battery-powered. This enables fast on-site testing that manufacturers can build into their drug formulation process.

How XRF Supports Regulatory Compliance

The Medicines and Healthcare products Regulatory Agency (MHRA) is the governing body that ensures pharmaceutical companies meet safety, quality, and efficacy standards. It provides drug licenses, monitors clinical trials, and enforces regulatory compliance.

Elemental analysis is a critical step on the road to compliance. Pharmaceutical manufacturers must follow ICH Q3D guidelines, which provide a risk-based method for testing elemental impurities in drugs.

Steps in ICH Q3D compliance include:

• Identifying sources of elemental impurities and assessing the potential risks to patients
• Following permitted daily exposure limits for each element
• Implementing controls related to supplier qualification, material specifications, and testing
• Maintaining compliance across development, manufacturing, and post-approval changes
• Documenting risk assessments and evidencing control methods during inspections

Supporting ICH Q3D compliance is one of the most important applications of XRF in pharmaceuticals manufacturing. Through precise elemental analysis, X-ray fluorescence spectroscopy ensures drugs remain within the allowed limits for heavy metals.

XRF ensures APIs and other raw materials meet regulatory standards. The non-destructive nature of XRF also helps companies minimise toxic waste disposal and remain compliant with green chemistry initiatives.

Finally, many X-ray fluorescence systems contain software features that support digital recording. Companies use this during site audits and inspections.

Advancements in XRF Technology

XRF systems continue to evolve. As they do, pharmaceutical companies can refine their testing and manufacturing processes.

Machine Learning

Real-time data analysis in XRF technology is becoming more advanced with the help of machine learning. This technology detects patterns based on data and makes decisions without the need for manual programming.
Machine learning supports faster, more accurate element analysis. It also reduces human error during spectral interpretation.

Detector Upgrades

High-performance detectors support faster and more precise toxic element detection in XRF systems. They’re more sensitive than traditional equipment and allow for lower trace-level detection limits. Modern X-ray fluorescence spectrometers use technology like Silicon Drift Detectors. These tools offer high spectral resolution, micro-analysis, and rapid data collection.

3D Imaging

This advanced technique facilitates the mapping of elemental distribution throughout tablets and capsules. This is crucial for ensuring drug purity and release performance.
3D imaging detects counterfeit medicines by quickly analysing the density of the entire tablet, not just the surface area. This supports drug purity and patient safety.

Conclusion

In an industry where accuracy and safety are vital, X-ray fluorescence is a powerful tool for ensuring quality control and compliance. From elemental analysis to real-time monitoring, the applications of XRF in pharmaceuticals manufacturing are invaluable. As this technology advances, pharmaceutical companies will rely on XRF imaging to meet the growing demand for specialised drugs.

One of the most important assessments for facilities in the UK is the Electrical Installation Condition Report (EICR). This formal inspection evaluates the safety and condition of a building’s electrical infrastructure.

Key Takeaways

• An Electronic Inspection Condition Report (EICR) is an essential step for manufacturing facilities operating with heavy electrical loads

• EICR codes alert companies to electrical faults that require immediate or preventive maintenance

• EICR inspections ensure companies remain compliant with UK electricity and workplace safety laws

• Pharmaceutical manufacturing facilities rely on EICRs to maintain operational efficiency and protect employees

What is an EICR?

An EICR is a comprehensive safety inspection that checks the condition of a building’s electrical infrastructure. It’s carried out by a qualified, registered electrician who’s undergone training in EICR inspections.

An inspector examines a facility’s fixed and hard-wired system for damage, natural wear, safety hazards, and compliance with the BS 7671:2018 Institute of Engineering and Technology (IET) Wiring Regulations.

The final report documents the condition of all electrical components and applies codes indicating whether or not immediate action is required to remediate an issue.

What the Report Covers

Manufacturing facilities depend on complex electronic systems. An EICR assesses these systems for safety and functionality.

Typical areas covered in the report include:

• Fixed wiring – These are permanently wired components such as circuits, light fittings, switches, and socket outlets. An EICR report details signs of deterioration, overheating, and the ability of each component to handle the electrical loads.
• Distribution boards – Technically considered fixed- or hard-wired, distribution boards control and protect circuits. The report includes the condition of circuit breakers, documenting signs of damage or overheating. It also records fuse ratings and whether a board is labelled properly.
• Earthing and bonding – Conductive equipment must be connected to the Earth. Nonconductive parts like pipes or conduits must be bonded, meaning they’re connected to each other. An EICR report confirms whether earthing and bonding requirements are met.
• Electrical fault testing – An inspector tests the overall system integrity. They perform Residual Current Device (RCD) trip time testing, insulation resistance testing, and check the continuity of protective conductors. The report shows whether circuits perform safely under fault conditions.

Reports vary based on the facility. Older buildings with outdated electrical systems often require extensive assessments and receive reports that reveal multiple issues. Inspections of new facilities are typically easier, faster, and result in fewer red flags.

A Breakdown of EICR Codes

An inspector uses a coded grading system to rate problematic electrical components after an EICR inspection. These codes reflect the severity of the problem and indicate the level of remedial action required.

The following codes are defined by BS 7671 guidelines:

• C1: Danger Present – This indicates a high risk of injury or fire, typically a result of exposed wires, overheating, or broken sockets. The inspector may make immediate repairs to ensure temporary safety until the issue is permanently fixed. A C1 results in an unsatisfactory EICR report.
• C2: Potentially Dangerous – This highlights electrical issues that could become a safety risk if not resolved. C2 ratings are often caused by earthing problems, inadequate wiring insulation, and missing RCD protection. They result in an unsatisfactory EICR report.
• C3: Improvement Recommended – This is an advisory rating indicating that an electrical system fails to meet best practices, but isn’t dangerous. C3 ratings typically result from outdated equipment, wear and tear, and inadequately labelled distribution boards. They result in a satisfactory EICR report.
• F1: Further Investigation – Inspectors use this code when they’re unable to access or test certain components. Examples include buried wires, untraceable circuits, or machinery that can’t be inspected unless shut down or dismantled. An F1 rating deems the EICR report unsatisfactory pending the successful inspection of the issue.

EICR codes are universal across the UK. However, code issuance varies based on the environment, equipment, and the inspector’s judgment.

For example, the same electrical defect can receive a different code depending on the risk level of the environment and how a piece of equipment is used.

Is an EICR Report Mandatory?

Commercial, industrial, and residential properties in the UK must obtain EICRs. When a report returns C1, C2, or F1 ratings, companies have a responsibility to perform remedial work within 28 days to stay compliant.

UK Electrical Safety Regulations

In the UK, companies must adhere to the following laws on electrical installation and maintenance:

• Electricity at Work Regulations 1989 (EAW) – Set of laws that enforce the safe construction, maintenance, and use of electrical systems by employers, employees, and the self-employed
• Health and Safety at Work etc. Act 1974 – Workplace safety law that requires employers to protect employees from electrical hazards by maintaining safe equipment and systems

Failing to adhere to these laws could result in serious injury, fines, operational disruption, or prosecution.

Why EICRs Matter in Pharmaceutical Environments

Pharmaceutical manufacturing relies on a stable electrical infrastructure. Production lines, labs, cleanrooms, HVAC systems, and automated equipment must function at optimal efficiency to support continuous manufacturing.

EICR inspections help pharmaceutical companies better understand the condition of their electrical systems. They pinpoint faults, degradation, and safety hazards, allowing for proactive maintenance before injury or operational disruption occurs.

High-Risk Electrical Loads in Production Facilities

Many of the raw materials used to make drugs are pharmaceutical chemicals in the form of liquids, gases, and powders. Some of these are highly flammable and pose potential safety hazards when used with electrical equipment.

The following equipment may be considered high-risk if not maintained:

• Manufacturing equipment – Mixing vessels, filling lines, dryers, and control boards run for long periods. They require a steady electrical supply to prevent overheating and circuit overloads.
• Reactor systems – These vessels support chemical reactions and blend raw materials such as biological buffers. Reactions often cause exothermic heat that can contribute to a vessel overheating. A reliable electrical supply supports temperature control and operational continuity.
• Analytical equipment – Devices such as spectroscopes, chromatography systems, and mass spectrometers are crucial for maintaining drug quality. Electrical components must be maintained to ensure operational reliability and prevent sparks, explosions, or high-voltage shocks.
• HVAC systems – Cleanrooms, labs, and temperature-controlled areas depend on HVAC systems to support sterilisation and drug consistency. Stable electrical systems prevent overheating or short-circuiting.

Electronic issues may go undetected until a breakdown or safety incident occurs. Regular EICR inspections are the best way to monitor and maintain the health of a facility’s electrical equipment.

How EICRs Support Safe, Compliant Production

The pharmaceutical industry is growing. Companies need a reliable manufacturing process to meet the rising demand for highly specialised drugs.

As innovative technology such as PAT systems becomes more common, EICRs play an increasingly crucial role in electrical safety and production oversight.

Protecting Staff

Inadequate earthing, damaged wiring, unauthorised equipment modifications, and overloaded circuits can lead to fires or electrical shock. EICR inspections identify these hazards before they endanger employees.

Maintaining Production Integrity

Equipment uptime is crucial in high-production pharmaceutical facilities. A single overloaded circuit or earthing malfunction can halt operations or compromise product quality.
EICR inspections ensure electrical systems can handle the power demands of pharmaceutical equipment and technology. They also identify faults before they occur, supporting preventive maintenance and production continuity.

Long-Term Compliance

EICRs create a record of a facility’s electrical condition. Reports include the inspection date, test results, and inspector’s name. They also show when a faulty system was remediated.

Companies often use EICR reports to prove compliance with BS 7671 guidelines. Reports also come in handy when proving safety due diligence to insurers or in the event of a regulatory investigation.

When Pharmaceutical Facilities Should Conduct EICR Inspections

While there are no legal requirements related to EICR inspection frequency, pharmaceutical manufacturing facilities must comply with the Electricity at Work Regulations 1989.

BS 7671 IET Wiring Regulations suggest the following EICR intervals for different environments:

• Industrial facilities – 3-5 years
• High-risk environments, such as chemical plants – 1-3 years
• Standard commercial buildings – 5 years

Most pharmaceutical manufacturing facilities are considered industrial or high-risk environments, depending on their chemical handling processes.

Companies should also conduct a new EICR inspection when:

• Electrical systems undergo upgrades or modifications.
• The facility experiences an electrical fault, shock, fire, flood, or equipment damage.
• A previous EICR specifies a shorter re-inspection time.
• The age or condition of the electrical system is unknown.
• The company expands into a new facility.

Conclusion

In pharmaceutical manufacturing, a reliable electrical infrastructure is essential for maintaining safe working conditions, protecting sensitive equipment, and ensuring uninterrupted production. Carrying out regular EICR inspections and addressing issues promptly reduces operational risks and ensures compliance in this highly regulated industry.

Traditional batch production, where end-product testing determines quality, is being replaced by real-time process control. Process Analytical Technology (PAT) and chemical flow measurement are integral to this approach.

Together, these tools support better quality control and pharmaceutical consistency.

Key Takeaways

• PAT systems support continuous manufacturing, compliance, and drug quality in the pharmaceutical industry

• Flow rate is a key variable in PAT frameworks that influences dosage accuracy, purity, solubility, and reaction efficiency

• Conducting chemical flow measurement requires instruments designed to track raw materials moving through a PAT system

• Integrating chemical flow measurement into PAT systems benefits pharmaceutical manufacturing operations and improves drug quality and accessibility

What is PAT in Pharmaceutical Manufacturing?

The US Food and Drug Administration (FDA) introduced PAT in 2004 to facilitate the shift from traditional end-product testing to a Quality by Design (QbD) model. Instead of testing a batch after completion, QbD builds quality into the production process.

The PAT framework combines robust technology and instruments such as spectroscopy, sensors, data systems, statistical models, and automated controls. Pharmaceutical companies use these tools to control and analyse their manufacturing process in real time.

PAT systems do this by tracking two key variables:

• Critical Quality Attributes (CQAs) – Physical, chemical, or biological characteristics of a drug that must be controlled to ensure quality.
• Critical Process Parameters (CPPs) – Factors that influence CQAs, such as flow rate, temperature, pH, pressure, and mixing speed.

If the system detects an imbalance in a CQA, it makes proactive changes to CPPs.

For example, a spectroscopy probe monitors a drug’s composition in real time and calculates the Active Pharmaceutical Ingredient (API) concentration (a CQA). If the API fluctuates, the PAT system adjusts the mixing speed (a CPP) to correct the ratio.

How PAT Promotes Quality & Compliance

Regulatory guidelines are in place to ensure drug safety and efficacy. The FDA and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) enforce guidelines by requiring compliant production processes and clinical trial data.

Compliance issues often result from inconsistent raw material feeds and equipment deviations. PAT systems catch these issues early, monitoring quality continuously and making real-time corrections before problems worsen.

PAT also serves as a compliance record. CQA and CPP analytics document drug quality at every production stage. This information comes in handy when proving compliance during facility inspections.

Flow Rate: A Critical Variable in PAT Systems

Drug manufacturing involves handling pharmaceutical chemicals in the form of liquids, gases, powders, and slurries. These raw materials are used to make everything from the cold and flu tablets you get at the grocery store to vaccines.

During the production process, raw materials flow through pipes, pumps, mixers, vacuums, and dies (steel casts that shape tablets). Flow rate refers to the volume, mass, and speed of materials moving through the system.

A Key Factor in High-Quality Pharmaceutical Manufacturing

Flow rate may seem like a minor operational function within an intricate production framework. However, it significantly influences how materials react, mix, and transform during manufacturing.

Flow rate directly impacts factors that contribute to a drug’s quality and consistency.

• Dosage accuracy – Flow plays an important role in obtaining proper dosages, especially during the production of tablets and capsules. Powders must flow into dies at a consistent rate to ensure dosage accuracy and weight uniformity.
• Solubility – The rate of solubility controls how quickly a drug dissolves and takes effect. Uneven flow can upset the balance, slowing absorption or reducing efficacy.
• Reaction efficiency – Controlled flow keeps reactants mixing evenly, which reduces impurities and improves heat transfer. Both are essential to a clean, efficient reaction.
• Purity – A drug’s purity refers to how much of the active ingredient is free of byproducts and unneeded chemicals. Proper flow promotes even chemical blending, controlled timing, and consistent heat distribution, all of which keep unwanted compounds out.

Real-time monitoring is the only sure-fire way to ensure flow rates remain consistent. This is where chemical flow measurement enters the process.

The Importance of Real-Time Chemical Flow Measurement

Consistent pharmaceutical manufacturing depends on proactive chemical flow measurement. This involves the use of innovative, highly accurate instruments to monitor the flow rate of liquids, gases, powders, and slurries.

Within a PAT framework, flow measurement gives pharmaceutical manufacturers visibility into each production step. When a deviation occurs, they can adjust conditions in real time before quality drops.

Flow measurement also identifies equipment degradation and shows how a manufacturing process behaves under varying conditions. This data supports predictive maintenance and process upgrades.

Flow Measurement Instruments Used in Pharma PAT Systems

Choosing the right instrument depends on the materials used, process requirements, and desired accuracy.

Here are some common flow measurement instruments used in PAT systems:

Coriolis Flow Meters

Known for their accuracy, Coriolis flow meters measure the volume, density, and temperature of liquids running through a PAT system. Inside the meter, small tubes vibrate as liquid moves through them. The liquid influences the vibration, and sensors translate that change to calculate flow conditions.

Coriolis flow meters provide continuous flow measurement and control, which contribute to a stable production process and drug consistency.

Ultrasonic Flow Meters

These instruments monitor the speed of purified water, viscous liquids, and gases as they move through pipes. Two sensors send ultrasonic signals with and against the flow to determine fluid velocity. This ensures the correct amount of material is moving through the system, which supports drug consistency and quality.

Ultrasonic flow meters don’t come into contact with raw materials. This makes them invaluable in situations where avoiding contamination is crucial.

Electromagnetic Flow Meters

Used for monitoring conductive liquids like biological buffers and API solutions, electromagnetic flow meters help ensure correct dosage and process control.

The meter creates a magnetic field in the system pipe. As liquid passes through the pipe, it generates an electric voltage. The faster the liquid is travelling, the stronger the voltage. Sensors detect the voltage to measure flow rate.

Thermal Mass Flow Meters

These meters use heat to measure the flow rate of gases. Small sensors gently heat the gas passing through a pipe. Gas carries some of the heat away as it passes the sensors. The meter then calculates the flow rate by detecting how much heat is lost.

Regulating gas flow helps maintain sterile conditions in drug production. These meters are widely used for coating tablets, ensuring proper dosing, and protecting sensitive ingredients from oxidation.

Loss-in-Weight (LIW) Feeders

LIW feeders ensure accurate API content in tablets by monitoring powder flow. The feeder tracks the weight of a hopper (a cone-shaped container) as it feeds powder into the system. If the flow rate is off, the system makes adjustments in real time.

Benefits of Integrating Chemical Flow Measurement Into PAT Systems

Chemical flow measurement isn’t optional in continuous manufacturing – it’s foundational. Integrating this critical step into PAT systems results in positive outcomes throughout the production process.

Operational benefits include:

• Product quality – Flow management reduces mixing variability, ensuring raw materials flow into the system in precise and consistent ratios. This is vital for maintaining the purity, dosage, and potency of drugs.
• Process control and understanding – By providing data that triggers real-time adjustments, flow measurement supports the automatic feedback loop in PAT systems. It also provides critical data that allows companies to better understand how each production step influences the final product.
• Waste reduction – The early detection of flow rate deviations prevents off-spec batches. This minimises waste and reduces costs associated with disposal and reworks.
• Scalability – Conducting chemical flow measurement during development helps companies scale their manufacturing operations. It pinpoints which flow rates should be used consistently as volume increases.
• Reduced downtime – Real-time flow measurement helps identify issues like equipment failure or flow restrictions. Early detection and proactive troubleshooting prevent production interruptions.

Beyond operational gains, chemical flow measurement helps pharmaceutical companies provide a reliable supply of safe, high-quality medications to the public.

Conclusion

From tighter regulatory control to the growing demand for specialised drugs, the pharmaceutical industry is under increasing pressure to optimise production. Chemical flow measurement integrated into PAT systems gives companies the real-time control to overcome these challenges.

Many activists, bloggers and researchers are trying to convince us that something sinister is going on behind our backs, so it’s no wonder people are being extra-cautious about the products they’re applying.

But should we believe everything we read? Here, we’ll aim to strip away the myths about chemicals in the cosmetic industry and expose the facts, from a scientific point of view.

Key Takeaways 

• Cosmetic ingredients are strictly regulated by bodies such as the European Chemicals Agency and the UK Office for Product Safety and Standards

• Safety depends on dose and use – not whether an ingredient is natural or synthetic

• Trace substances in cosmetics are sometimes present but at safe levels, as confirmed by the U.S. Food and Drug Administration

• There is no strong scientific evidence linking everyday cosmetics to cancer, according to the American Cancer Society

• Robust global regulations ensure products are safe before reaching consumers

Are There Really Dangerous Chemicals in Cosmetics?

There are lots of myths and scare stories about cosmetics and chemicals, and concerns over safety are understandable.

However, the reality is more nuanced. Ingredients – whether natural or synthetic – are strictly assessed for safety by bodies such as the European Chemicals Agency and the UK Office for Product Safety and Standards. 

Crucially, safety depends on concentration and use, meaning substances that may be harmful in high amounts can be safe in controlled formulations. With rigorous regulations and testing in place, modern cosmetics are designed to be both effective and safe for everyday use.

Natural vs. Synthetic Chemicals

In order to understand more about what’s in your cosmetics, it’s helpful to look at the differences between synthetic and naturally occurring chemicals.

Chemicals produced or mixed in a factory are manufactured in a clean, approved environment.

Most chemical companies work to strict quality standards and manufacturing guidelines to ensure that products are safe for the consumer. Man-made chemicals are added to products in a controlled manner using specific, tested quantities. This makes them much easier to regulate and monitor than naturally occurring chemicals.

According to the Center for Research on Ingredient Safety at Michigan University, natural and synthetic ingredients can be chemically identical – and there’s nothing to say that natural chemicals were safer than synthetic ones. 

In fact, many chemicals that come from nature can be toxic, so we can’t group them all together. Ethanol and lead, for example, occur naturally but do present some dangers if ingested irresponsibly. There have actually been negative reactions in the media about the presence of lead in cosmetics, so let’s look at that next.

Does Lipstick Contain Dangerous Amounts of Lead?

Lipstick does tend to contain trace amounts of lead (which occurs naturally in air, water, and soil), but beauty products are routinely tested for safety by national standards bodies. 

For example, cosmetics in the US are fully monitored by the FDA before they can be sold to the public.

The FDA concluded that lead is present in such tiny amounts that it has no adverse effect on humans; there’s just not enough exposure in lipstick for it to be classed as toxic.

The Personal Care Products Council (PCPC) confirmed that the trace levels of lead found in lipstick are not a cause for concern and the US is yet to record a case of lead poisoning as a result of lipstick use.

So, there’s no need to panic when buying or using make-up. Simply use cosmetics you like and that don’t cause a reaction to your skin. As long as your make-up and skincare products are purchased from legitimate brands, they’re likely to be perfectly safe.

The Cancer Rumours

Concerns linking everyday cosmetic products to cancer are often amplified online, but they are not supported by robust scientific evidence. While cancer is a serious and complex disease, it’s crucial that discussions around it remain grounded in credible research rather than misconception. 

Let’s take a look at a couple of commonly circulated myths about personal care products and cancer:

1) “Antiperspirants Cause Cancer” 

This claim has circulated widely, but organisations such as the American Cancer Society state that there is little scientific evidence to support a link between underarm antiperspirants and cancer. Current research indicates it is highly unlikely that these products pose a cancer risk when used as intended.

2) “Cancer Patients Can’t Wear Make-Up Because of Chemicals”

There is no evidence to support the idea that cosmetic use is unsafe for cancer patients in general. While individuals undergoing treatment may experience increased skin sensitivity, guidance from the NHS focuses on comfort and hygiene rather than avoiding cosmetics altogether. 

In fact, make-up is often used to support wellbeing and confidence during treatment, so it has a positive role to play beyond aesthetics.

Overall, while it is important to approach health-related claims with care, current scientific and medical consensus does not support the notion that everyday cosmetic products are linked to cancer.

Are There Enough Regulations Around Chemicals In Cosmetics?

Concerns that governments take a “hands-off” approach to cosmetic safety are understandable, but they do not reflect how the industry is regulated in practice. Across major markets, cosmetic products are subject to comprehensive oversight designed to protect consumers.

For example, Health Canada maintains a “hotlist” of restricted or prohibited substances and requires ingredient disclosure for products placed on the market. 

In the US, the Cosmetic Ingredient Review – which includes experts from the U.S. Food and Drug Administration and independent scientists – evaluates the safety of cosmetic ingredients based on available research.

In Europe and the UK, regulations are particularly stringent. Under frameworks such as Regulation (EC) No 1223/2009, every cosmetic product must undergo a formal safety assessment before reaching the market, and only approved ingredients can be used. UK products must also comply with national safety legislation, ensuring continued oversight post-Brexit.

While no system is entirely risk-free, these frameworks demonstrate that cosmetic safety is actively managed rather than overlooked. Ultimately, products available on the market must meet strict scientific and regulatory standards designed to ensure they are safe for intended use.

Conclusion

It’s natural and understandable to have concerns about chemicals in cosmetics, but current evidence shows that products are developed and regulated with safety as a priority. With strict testing and oversight in place, consumers can be confident that cosmetics are safe when used as intended.

Key Takeaways

• UK REACH replaced EU REACH in the UK after Brexit (1 January 2021)

• It regulates chemicals through four processes: Registration, Evaluation, Authorisation, and Restriction

• Companies must submit hazard and safety data under the principle “no data, no market”

• Substances of Very High Concern (SVHCs) may require authorisation or face restrictions

• Industry is responsible for ensuring chemical safety, with regulatory oversight.

What is REACH in the UK?

REACH is an abbreviation of Registration, Evaluation, Authorisation and Restriction of Chemicals.  It is the UK’s main regulation for managing chemical substances, and applies to most chemicals that are either made here or imported into the country.

Before the UK left the European Union (EU) in January 2020, the EU REACH laws applied to chemical manufacturing and importing in the UK and across the European community. Following Brexit, EU laws were brought into UK laws – and as of 1st January 2021 are known as UK REACH. All of the key principles were retained, however.

If your company makes, sells or imports chemicals in both the UK and the EU, you need to comply with both EU REACH and UK REACH regulations.

REACH is concerned with the safe use of chemicals, aiming to:

• Protect human health and the environment from harmful chemicals
• Ensure companies understand and manage chemical risks
• Promote safer alternatives and reduced animal testing
• Maintain a safe and competitive chemical market

Another major aim of REACH is to ensure communication in the supply chain, from the manufacturer to the end-user (down-stream user or distributor).

Information is needed to use chemicals safely, including health, safety and environmental properties, risks and risk management measures. All of this information is required to be passed up and down the supply chain.  The primary tool for supply of this information is in the form of a Safety Data Sheet (SDS).

Ultimately, companies must identify hazards and risks of chemicals they produce or import, and demonstrate that substances can be used safely. The principle to remember is – “no data, no market”.

The four pillars of REACH regulation

UK REACH regulations focus on four key processes:

1: Registration

Manufacturers and importers must register chemicals with the Health and Safety Executive (HSE). They must submit data on properties, hazards, and safe uses.

2: Evaluation

Authorities evaluate the submitted safety data, and further testing may be required if risks are unclear.

3: Authorisation

Substances of very high concern (SVHCs) require special permission for use. These may include carcinogenic, mutagenic, or reproductive toxins. The goal is to replace dangerous chemicals with safer alternatives.

4: Restriction

Some chemicals are banned or limited if they pose unacceptable risks. Restrictions can apply to manufacturing, sale, or use.

Conclusion

UK REACH established an independent regulatory framework for chemicals following the UK’s departure from the EU. By requiring companies to generate safety data, assess risks, and control hazardous substances, it aims to protect human health and the environment while ensuring chemicals are used safely across supply chains.

For further information on REACH we recommend consulting the Health and Safety Executive website or the European Chemicals Agency.  This information was correct at the time of writing. Please note we cannot be held responsible for accuracy.

No matter how long they’ve known or worked in the industry, even experts can trip up on the key terms they use regularly. 

When searching online for definitions for particular terms in the chemical industry, any information on them can be either fragmented or overly detailed – this can lead to you searching more than one website to put together a competent definition for a key word or phrase.

We’re here to help, with our easy-to-understand glossary of key terms used in the chemical manufacturing industry.

Technical Terms in the Chemical Industry

We’ve compiled an A-Z glossary of many of the technical terms you’ll come across in the chemical industry, to help our customers understand some of the widely used (and not so common) product names and specialised vocabulary used in this sector. 

The glossary is packed with useful and clear information, as well as diagrams and videos to illustrate where necessary. We describe each term in sufficient detail as simply as possible, so you can have access to a quick point of reference whenever you’re confused about a definition.

Key Takeaways 

• We’ve put together a clear, simple A–Z glossary of chemical industry terms

• It covers science, materials, processes, and regulations

• Designed as a quick, reliable reference point

• Includes visuals to support understanding

• Built using real industry expertise

What’s in Our Chemical Glossary?

The glossary provides a reference of key terms used in the chemical manufacturing industry, covering a broad mix of scientific concepts, materials, packaging methods, safety practices, and regulatory standards. 

It explains everything from basic chemistry ideas (such as  pH and buffers) to industry-specific processes (such as blending and repacking). Plus, important compliance frameworks such as transport rules, labelling systems, and quality certifications.

Categories the glossary aims to cover include:

• Chemical packaging and storage
• Chemistry and scientific terms
• Materials
• Regulations in the chemical industry
• Standards and accreditations
• Training and problem-solving in the industry

We used our expertise and knowledge of the chemical and manufacturing industry to put the guide together.

We have in-house experts in all areas of chemical manufacturing, including chemists, chemical bottling, and chemical packing experts. If there are any terms that you feel should be included, then please let us know.

Need More Help? 

If you need assistance with finding or buying a particular product, or understanding any of the terms used on our website – we’re here to help. Get in touch with the friendly ReAgent team by calling 0800 9555 798.

Conclusion

Understanding chemical industry terminology doesn’t have to be complicated. Our glossary brings together essential terms in one accessible place, helping both beginners and experienced professionals quickly find clear, reliable definitions and navigate the industry with confidence.

Through targeted partnerships, donations, and active involvement, the ReAgent Foundation is focused on creating a positive impact on people, communities, and the environment.

Watch Our Video to Learn About the ReAgent Foundation

The ReAgent Foundation’s Beginning

Years ago, Rich Hudson, CEO of ReAgent and Chair of the ReAgent Foundation, had a vision of starting a corporate foundation. The business used to make small contributions to employee causes, but Rich had his sights on bigger things. ReAgent’s continued growth eventually made his vision possible.

“When ReAgent was a lot smaller, it was more challenging to run the business. It was a fight for survival, essentially,” says Rich Hudson. “I used to daydream about one day, the company being so well established that we could afford to actually start giving back.”

The ReAgent Foundation was established as a registered charity in 2025 and officially launched at the beginning of 2026.

The ReAgent Foundation’s Focus

The ReAgent Foundation operates on three core values: responsibility, integrity, and community. It believes every company has a responsibility to improve communities around them.

Its charitable work focuses on three strategic pillars:

• Protecting the environment
• Improving the lives of those with life-altering illnesses
• Promoting STEM education

Each year, the ReAgent Foundation partners with three organisations, selecting one aligned with each of its pillars. It supports each partner with a charitable donation and dedicated volunteer assistance.

2026 Partnerships

The ReAgent Foundation’s 2026 partnerships demonstrate its commitment to wellbeing, STEM education, and environmental conservation.

MS-UK

MS-UK empowers people living with multiple sclerosis to live healthier, happier lives. They offer a mental health helpline, online and in-person activities, peer support groups, and other services. MS-UK also raises awareness through MS education and fundraising projects.

Science Museum

The Science Museum educates and inspires young minds in the areas of science, technology, engineering, and mathematics (STEM). Their award-winning exhibitions, interactive displays, and live demonstrations promote hands-on learning.

Snowdonia Society

The Snowdonia Society is an environmental charity that protects the landscape and wildlife of Snowdonia. They work with local authorities on conservation initiatives and organise volunteer programmes focusing on environmental conservation.

Hands-on Support

For the ReAgent Foundation, creating a real impact involves more than donations.

ReAgent’s volunteer day programme allows employees to take time off to support the ReAgent Foundation’s partners. This hands-on work is key to making a tangible impact on people’s lives and the environment.

Annual fundraising challenges give team members another opportunity to get involved. This year’s fundraising event is the 24-hour Three Peaks Challenge. Participants will raise money for the ReAgent Foundation as they attempt to hike Ben Nevis in Scotland, Scafell Pike in England, and Snowdon in Wales.

Long-Term Impact

Rich has big ambitions for the ReAgent Foundation. He wants it to be immensely impactful and believes it will be.

“Long term, I hope that the Foundation has an enormous impact. Like ReAgent, I honestly believe the sky’s the limit. And I think the sky’s the limit for the Foundation as well, ” says Rich.

As ReAgent grows, the ReAgent Foundation will expand its reach and create lasting benefits for communities and the environment.